Skip to content
MedsAcross

Medicine

Haloperidol decanoate 500 mg/5 mL injection

Haloperidol decanoate · Intramuscular
Available on requestPrescription onlyUS FDAGeneric name

Haloperidol decanoate 500 mg/5 mL injection is a generic prescription medicine for intramuscular use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not refrigerate or freeze. Store at 20°C to 25°C (68°F to 77°F). Protect…

Key facts

Active ingredient (INN)
Haloperidol decanoate
Brand
Sold under the generic name
Strength
500 mg/5 mL
Dosage form
Injection
Route
Intramuscular
Packs
1 vial of 5 mL, 5 vials of 5 mL, 10 vials of 5 mL and 16 more
Manufacturers
Zydus LifesciencesIndiaLifestar PharmaIndiaCaplin SterilesIndiaGland PharmaIndiaSomerset TherapeuticsBluePoint LaboratoriesArmas PharmaceuticalsFresenius KabiHikma PharmaceuticalsMeitheal Pharmaceuticals
Origin register
US FDA, United States
Storage
Do not refrigerate or freeze. Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 October 1998
Identifiers
RxCUI 859871, 1719803, 1719862 +1DailyMed set ID 3d011250-a517-4c27-8ce3-d59d441ea61c, b3167043-585f-482f-b8a7-591bc2721bd3, f2d14406-2ad4-4c5b-9c24-a026f27b415d +11NDC 68001-659, 25021-834, 68001-582 +11Application ANDA211180, ANDA205241, ANDA209101 +5

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70710-1464-1Zydus LifesciencesIndia14 November 2019
5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70710-1464-5Zydus LifesciencesIndia14 November 2019
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70771-1854-1Zydus LifesciencesIndia14 November 2019
5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70771-1854-5Zydus LifesciencesIndia14 November 2019
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose65145-169-01Caplin SterilesIndia26 May 2025
1 vial in 1 carton / 5 mL in 1 vial68083-138-02Gland PharmaIndia16 January 2017
5 vial in 1 carton / 5 mL in 1 vial70756-625-05Lifestar PharmaIndia23 May 2023
10 vial in 1 carton / 5 mL in 1 vial70756-625-10Lifestar PharmaIndia23 May 2023
1 vial in 1 carton / 5 mL in 1 vial70756-625-85Lifestar PharmaIndia23 May 2023
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70069-384-01Somerset Therapeutics13 April 2019
5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose70069-384-05Somerset Therapeutics4 April 2019
1 vial in 1 carton / 5 mL in 1 vial70069-868-01Somerset Therapeutics29 September 2025
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose72485-522-01Armas Pharmaceuticals15 May 2026
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose63323-471-05Fresenius Kabi12 July 2000
1 vial in 1 box / 5 mL in 1 vial0143-9296-01Hikma Pharmaceuticals1 October 1998
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose71288-504-05Meitheal Pharmaceuticals26 July 2021
1 vial in 1 carton / 5 mL in 1 vial25021-834-05Sagent Pharmaceuticals15 November 2017
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose68001-582-41BluePoint Laboratories11 August 2023
1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose68001-659-41BluePoint Laboratories1 October 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 January 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Haloperidol decanoate

Clinical summary

Haloperidol decanoate is a typical antipsychotic indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy. It is available as injection for intramuscular use. MedsAcross supplies Haloperidol decanoate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Haloperidol decanoate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Haloperidol decanoate 500 mg/5 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.